MedPath

The efficacy and safety analysis of Peg-IFN/RBV/Vitamin D3 therapy for liver cirrhosis with hepatitis c persistent infection: RCT Study

Not Applicable
Recruiting
Conditions
iver cirrhosis with hepatitis c persistent infection
Registration Number
JPRN-UMIN000007400
Lead Sponsor
Division of Gastroenterology, Tohoku University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Pregnant Drug allergy Hear Disease Abnormal Hb Renal Failure Sever Liver Disease Autoimmune Hepatitis etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SVR rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath